1. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
2. Which type of research involves intervention, treatment, or medication programs using human subjects?
3. What is the fee for the renewal of registration of a new drug?
4. When does an Inspector need to divide a sample into three portoons instead of four?
5. What is the purpose of the Committee on Drugs Evaluation?
6. Which of the following criteria should promotional claims about drugs adhere to?
7. In what type of premises should the manufacturing of drugs by way of basic or semi-basic manufacture take place?
8. What action should the Authority take in response to objections raised by the Auditor-General?
9. What is the role of the Quality Control Department in the manufacturing process?
10. Under what conditions can the aid from the research fund be withdrawn and a clinical trial terminated?
11. Who serves as the ex-officio Chairman of the Appellate Board?
12. What is the purpose of Schedule-III of the DRAP Act?
13. What is the term of office for members of the Registration Board?
14. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
15. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
16. What action should the Authority take in response to objections raised by the Auditor-General?
17. The Central Research Fund fee collected by the Authority will be utilized for:
18. Which authority is responsible for issuing licences to manufacture drugs by way of repacking under section 18 of ordinance in a province?
19. What is the main duty of a Federal Inspector?
20. Within what time frame should the Authority submit its annual report to the Federal Government?
21. According to the schedule in the Drugs (Specifications) Rules, what specifications should drugs bear that reference publications specified under sub-clause (ii) of clause (z) of Section 3?
22. Within what time frame should the Authority submit its annual report to the Federal Government?
23. When does an Inspector need to divide a sample into three portoons instead of four?
24. Who may physically inspect an imported consignment, draw samples, and order the importer not to sell or dispose of the drug for a specific period?
25. Which of the following offenses punishable under Schedule-III is non-cognizable?
26. What is the definition of "promotion" for the purposes of Schedule G of 1976 Rules?
27. Who has the authority to establish the Drug Regulatory Authority of Pakistan?
28. What is the purpose of 'the Drugs (Federal Inspectors, Federal Drug Laboratory and Federal Government Analysts) Rules, 1976'?
29. What is the primary purpose of the Committee of Experts on Drug Research?
30. In what circumstances shall a drug not be deemed misbranded or adulterated?
31. What is the purpose of the Drugs (Research) Rules, 1978?
32. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
33. Which of the following is NOT considered as "Therapeutic goods" under the Act?
34. What is the Appellate Board's authority to call for the record of a case for review?
35. What provision allows an exporter to recall issues already made from a batch of drugs that have been found to be in contravention of the Act or rules of 1976?
36. What is the penalty for a person who fails to provide information requested by the Authority?
37. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
38. What stage of investigation on human beings involves determining safety, effectiveness, and common side effects of a drug?
39. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
40. Under what conditions are drug advertisements to the general public generally permitted?
41. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
42. What kind of offense is non-cognizable under the Drugs Act 1976?
43. Under what circumstance can an exporter withdraw a batch of drugs from export after being informed by the licensing authority?
44. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
45. What is the purpose of an "airlock" in pharmaceutical manufacturing?
46. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
47. What does an Inspector require from a person during a search or seizure under Schedule-V?
48. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
49. What ethical criteria should be followed for medical drug promotion?
50. What condition must be met for a drug or substance to be advertised through press without reference to the Federal Government?
51. Which power of the Inspector requires specific authorization by the Government?
52. What does the term "Advertise" mean under Schedule-II?
53. What condition must be met for an application for renewal of a licence to be entertained?
54. What is the short title of the rules that govern the Drugs Appellate Board?
55. The Drugs Act, 1976 extends to which of the following areas?
56. Which type of ophthalmic preparations is allowed to have a preservative?
57. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
58. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
59. According to the Drug Licensing, Registering & Advertisement rules 1976, what type of information should advertisements to physicians and health-related professionals be consistent with?
60. Under what conditions is contract manufacture permissible?
61. What substances are NOT included in the definition of "Drug" under Schedule-I?
62. What are the conditions that the Central Licensing Board must ensure are complied with before granting or renewing a licence to manufacture drugs by way of basic or semi-basic manufacture?
63. What is the penalty for giving a false warranty in respect of any therapeutic good or applying a warranty given for another therapeutic good?
64. In which circumstances may the Registration Board register a drug on its own motion?
65. What is the purpose of an "airlock" in pharmaceutical manufacturing?
66. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
67. What form should be used for applying for the grant or renewal of a licence to manufacture drugs?
68. For veterinary drugs, what is the source of specifications if they are not approved by the Registration Board?
69. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
70. Who is responsible for maintaining records of quarterly production and disposal of a drug?
71. What is the consequence of violating the conditions of a license to import drugs or the provisions of the Act?
72. What is the purpose of the license to manufacture drugs for experimental purposes?
73. What are "Medicated Cosmetics" under Schedule-I?
74. Under what condition can finished drugs be imported?
75. Which of the following is NOT a source of financing the Drug Regulatory Authority Fund?
76. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
77. What is the definition of "Biological Drugs (Ready-to-fill form)" under Schedule-I?
78. What is the condition under which printing of labeling for therapeutic goods is allowed under Schedule-II?
79. Who can revoke an order passed under Section 32 of the DRAP Act, 2012?
80. The Authority may open its accounts with:
81. What does an Inspector require from a person during a search or seizure under Schedule-V?
82. Who has the power to institute a prosecution for a contravention of any provision of the DRAP Act, 2012, and The Drugs Act, 1976?
83. In case of an appeal against the decision of the Registration Board rejecting an application for registration of a drug, what statement is required to be submitted?
84. What is the maximum period for which an Inspector can forbid a person in charge of premises from removing or dispensing therapeutic goods?
85. What are "Medical Devices" under Schedule-I?
86. Which power of the Inspector requires specific authorization by the Government?
87. What is the maximum quantity of a single drug that can be imported for personal use without exceeding the limit?
88. When can deviations be made from the information submitted during the registration of a drug?
89. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
90. When a Federal Inspector is not competent to take action under Schedule-IV, what should he do?
91. What labeling requirements apply to drugs manufactured for experimental purposes?
92. What does the term "Advertise" mean under Schedule-II?
93. Which of the following statements about advertisement material is NOT true?
94. What is the commencement date for the Drugs (Specifications) Rules, 1978?
95. Which Division is responsible for the evaluation, assessment, and registration of pharmaceutical drugs for human beings and animals?
96. What is the primary focus of basic research in the context of the Drugs (Research) Rules?
97. What are "Medical Devices" under Schedule-I?
98. In which situations may the Registration Board provisionally register a drug for a period of two years?
99. What is the role of the Quality Control Department in the manufacturing process?
100. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
